Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This multicenter, prospective, randomized trial was designed to evaluate the role of
thalidomide with or without dexamethasone as a maintenance therapy for multiple myeloma
patients after a single autologous stem cell transplantation.
Phase:
Phase 3
Details
Lead Sponsor:
Grupo de Estudos Multicentricos em Onco-Hematologia